{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:56:24Z","timestamp":1793048184401,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clim.2013.10.009","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T10:31:22Z","timestamp":1382783482000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4+ T cells of psoriasis vulgaris"],"prefix":"10.1016","volume":"150","author":[{"given":"Ming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-yue","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-jin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2013.10.009_bb0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clim.2013.10.009_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2013.10.009_bb0015","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1038\/jid.1995.18","article-title":"Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia","volume":"105","author":"Bata-Csorgo","year":"1995","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2013.10.009_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.sder.2010.03.001","article-title":"New insights in the immunologic basis of psoriasis","volume":"29","author":"Nograles","year":"2010","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.clim.2013.10.009_bb0025","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1747.1998.00419.x","article-title":"Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets","volume":"111","author":"Szabo","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2013.10.009_bb0030","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","article-title":"Identification and functional characterization of human CD4(+) CD25(+) T cells with regulatory properties isolated from peripheral blood","volume":"193","author":"Jonuleit","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2013.10.009_bb0035","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.193.11.1295","article-title":"Human CD25(+) CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function","volume":"193","author":"Levings","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2013.10.009_bb0040","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1182\/blood-2011-11-388918","article-title":"Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells","volume":"119","author":"Tai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.10.009_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2013.10.009_bb0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri1488","article-title":"Forkhead-box transcription factors and their role in the immune system","volume":"4","author":"Coffer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0055","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature05478","article-title":"FOXP3 occupancy and regulation of key target genes during T-cell stimulation","volume":"445","author":"Marson","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clim.2013.10.009_bb0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jdermsci.2008.04.015","article-title":"Dynamic frequency of CD4+ CD25+ FOXP3+ Treg cells in psoriasis vulgaris","volume":"51","author":"Chen","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2013.10.009_bb0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000238305","article-title":"Circulating CD4+ CD25bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients","volume":"219","author":"Quaglino","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clim.2013.10.009_bb0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1684\/ejd.2011.1362","article-title":"CD4+ CD25+ T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement","volume":"21","author":"Richetta","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.clim.2013.10.009_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+ CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.clim.2013.10.009_bb0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0625.2012.01462.x","article-title":"miR-21 is up-regulated in psoriasis and suppresses T cell apoptosis","volume":"21","author":"Meisgen","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2013.10.009_bb0090","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.1202695","article-title":"MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine\/threonine kinase 40","volume":"190","author":"Xu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2010.03.004","article-title":"MicroRNAs and potential target interactions in psoriasis","volume":"58","author":"Zibert","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2013.10.009_bb0100","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.34505","article-title":"Decreased microRNA-142-3p\/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus","volume":"64","author":"Ding","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2013.10.009_bb0105","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/art.30196","article-title":"MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1","volume":"63","author":"Zhao","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2013.10.009_bb0110","article-title":"MicroRNAs: emerging regulators of immune-mediated diseases","author":"Tomankova","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2013.07.003","article-title":"The role of miRNA in inflammation and autoimmunity","author":"Singh","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2013.10.009_bb0120","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1582-4934.2008.00398.x","article-title":"Hypoxia response and microRNAs: no longer two separate worlds","volume":"12","author":"Ivan","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clim.2013.10.009_bb0125","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1073\/pnas.0803304105","article-title":"Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer","volume":"105","author":"Foekens","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2013.10.009_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.24687","article-title":"Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival","volume":"126","author":"Greither","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clim.2013.10.009_bb0135","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cncr.25009","article-title":"Hsa-miR-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer","volume":"116","author":"Gee","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clim.2013.10.009_bb0140","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1161\/CIRCULATIONAHA.109.928424","article-title":"MicroRNA-210 as a novel therapy for treatment of ischemic heart disease","volume":"122","author":"Hu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2013.10.009_bb0145","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.febslet.2012.03.011","article-title":"MicroRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-kappaB1 in murine macrophages","volume":"586","author":"Qi","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clim.2013.10.009_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000330330","article-title":"Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response","volume":"223","author":"Quaglino","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clim.2013.10.009_bb0155","doi-asserted-by":"crossref","first-page":"e19806","DOI":"10.1371\/journal.pone.0019806","article-title":"GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4","volume":"6","author":"Racz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2013.10.009_bb0160","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.1002620","article-title":"Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression","volume":"186","author":"Sahoo","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0165","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"FOXP3 programs the development and function of CD4+ CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor FOXP3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.clim.2013.10.009_bb0175","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+) CD25(+) FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0185","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature05479","article-title":"Regulatory T-cell functions are subverted and converted owing to attenuated FOXP3 expression","volume":"445","author":"Wan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clim.2013.10.009_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4110\/in.2011.11.1.11","article-title":"The role of microRNAs in regulatory T cells and in the immune response","volume":"11","author":"Ha","year":"2011","journal-title":"Immune Netw."},{"key":"10.1016\/j.clim.2013.10.009_bb0195","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.clim.2013.10.009_bb0200","article-title":"Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses","author":"Terras","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2013.10.009_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1615\/CritRevImmunol.v32.i1.40","article-title":"Regulation generation: the suppressive functions of human regulatory T cells","volume":"32","author":"Goodman","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.10.009_bb0210","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"FOXP3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161300274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161300274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T23:05:13Z","timestamp":1716073513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161300274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S152166161300274X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2013.10.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4+ T cells of psoriasis vulgaris","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2013.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}